Brain‐age prediction from neuroimaging data provides a proxy of biological aging, yet most models rely on structural magnetic resonance imaging (MRI), a modality that captures macroanatomy but offers limited biological specificity. We tested whether integrating molecular‐enriched functional connectivity (FC) from resting‐state functional MRI (rs‐fMRI) data improves brain‐age prediction and biological explainability. We analyzed MRI data of 2120 healthy adults (1243/877 F/M; 18–90 years) from three public datasets. Molecular‐enriched connectivity maps were derived with Receptor‐Enriched Analysis of functional Connectivity by Targets (REACT) using receptor‐density templates for the dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporter systems. Support vector regression models were applied to predict chronological age from molecular‐enriched FC, structural morphometry, or both combined. The effect of multi‐site variability was mitigated via ComBat harmonization with and without Empirical Bayes pooling. We additionally conducted a common‐parcellation analysis to assess the impact of differing parcellations between modalities. Single‐transporter molecular‐enriched FC explained up to 51% of age variance. The most predictive transporter varied by dataset, with DAT dominating in the harmonized and common‐parcellation settings. Combining the three molecular‐enriched maps consistently improved prediction over any single map and increased explained variance up to 64%. Structural morphometry remained the strongest single modality overall. In the merged multi‐site cohort using a common parcellation, adding transporter‐enriched FC to structural features yielded a small but consistent reduction in prediction error (mean absolute error (MAE) from 6.02 to 5.81 years), supporting limited complementarity between the two modalities. Residual‐level paired comparisons across repeated cross‐validation confirmed that this improvement is statistically reliable but modest in magnitude. In contrast, when different parcellations were applied, incorporating molecular‐enriched FC into brain age prediction resulted in a 2% higher MAE compared to structural morphometry alone, suggesting that parcellation mismatch may obscure the functional contributions. In conclusion, molecular‐enriched FC is a feasible and biologically informative extension to brain‐age modeling; however, its added predictive value over structural morphometry was modest and depended on harmonization and atlas alignment.
Marco Pinamonti, M. Moretto, Valentina Sammassimo et al.· Human Brain Mapping· 0 citations
Dopaminergic signalling is critical for regulating large-scale brain network dynamics and is implicated in the pathophysiology of psychotic disorders. 22q11.2 deletion syndrome (22q11DS), a high-penetrance genetic risk factor for schizophrenia, is associated with both dopaminergic alterations and disruptions in functional connectivity (FC), yet the degree to which these separate people with 22q11DS from healthy controls and their inter-relationship remains unclear. Eighteen individuals with 22q11DS (no history of psychosis or antipsychotic use) and 22 controls underwent [18F]-DOPA PET imaging to assess striatal dopamine synthesis (indexed by Kicer values) and resting-state fMRI to examine FC. Classification performance using FC, dopamine measures, and their combination was assessed via repeated 10-fold cross-validation. Associations between Kicer, connectivity, and psychotic symptoms were evaluated using linear regression. FC alone classified 22q11DS with 68% balanced accuracy (p = 0.004), Kicer alone with 77% (p < 0.001), and combined measures with 85% balanced accuracy (p < 0.001), indicating additive value. The somatomotor and auditory networks contributed most to group discrimination. Across individuals, higher Kicer was significantly associated with more control-like connectivity profiles (p = 0.011), with significant effects in all striatal subdivisions. No association was found between FC and subclinical psychotic symptoms. This multimodal study demonstrates a significant association between striatal dopamine synthesis capacity and functional brain network architecture in 22q11DS. Higher dopamine synthesis was linked to more normative FC, potentially suggesting FC differences reflect a compensatory, rather than pathogenic role. These findings bridge genetic risk at the 22q11.2 locus with dopamine dysfunction and large-scale networks, offering novel insights into the neurobiology of 22q11DS and related neuropsychiatric risk.
V. Mancini, M. Rogdaki, S. Jauhar et al.· Molecular Psychiatry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.